Drug-Induced Hepatotoxicity
The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Abstract
Drug-induced hepatic injury accounts for more than 50 percent of cases of acute liver failure in the United States. More than 75 percent of idiosyncratic drug reactions result in liver transplantation or death. This review discusses the pathogenesis of drug-induced liver injury, common adverse drug reactions involving the liver, and the drug-approval process. Monitoring for and recognition of drug-induced hepatotoxicity may prevent some cases of acute hepatic failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that many variables, such as genetic variability, race, sex, age, metabolic capacity, drug-drug interactions, and preexisting diseases, contribute to individual susceptibility and toxicity of idiosyncratic drugs (Lee, 2003).”
From Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent (2012) · cites this paper as Lee, 2003
In the citing paper
“Under these limited conditions, two-dimensional (2D) monolayered cells exhibit altered biological features, including morphology, function, hepatic polarity, and genotype expression (Lasser et al., 2002;Lee, 2003;Ma et al., 2023).”
From Fast formation and maturation enhancement of human liver organoids using a liver-organoid-on-a-chip (2024) · cites this paper as Lee, 2003
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Self-citationEarly indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29666-5 · Cited by 1,737
Role of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity
Guengerich, F. P. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002583 · Cited by 1,655
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
Jaeschke, H. (2002) · Toxicological Sciences · doi:10.1093/toxsci/65.2.166 · Cited by 1,304
McDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M., & Clift, R. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00003 · Cited by 1,202
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102
Weinshilboum, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020021 · Cited by 1,031
Timing of new black box warnings and withdrawals for prescription medications
Lasser, K. E. (2002) · JAMA · doi:10.1001/jama.287.17.2215 · Cited by 1,005
The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
Wrighton, S. A., & Stevens, J. C. (1992) · Critical Reviews in Toxicology · doi:10.3109/10408449209145319 · Cited by 944
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
Henry, J. A., Jeffreys, K. J., & Dawling, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)91469-o · Cited by 729
Incidence of drug-induced hepatic injuries: A French population-based study
Sgro, C., Clinard, F., Ouazir, K., Chanay, H., Allard, C., Guilleminet, C., Lenoir, C., Lemoine, A., & Hillon, P. (2002) · Hepatology · doi:10.1053/jhep.2002.34857 · Cited by 716
Molecular Pathogenesis of Cholestasis
Trauner, M., Meier, P. J., & Boyer, J. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391707 · Cited by 706
Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions: A Systematic Review
Phillips, K. A., Veenstra, D. L., Oren, E., Lee, J. K., & Sadee, W. (2001) · JAMA · doi:10.1001/jama.286.18.2270 · Cited by 705
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
Alternative Medicine — The Risks of Untested and Unregulated Remedies
Angell, M., & Kassirer, J. P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391210 · Cited by 688
Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)
DeLeve, L. D., Shulman, H. M., & McDonald, G. B. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-23204 · Cited by 664
McKenzie, R., Fried, M. W., Sallie, R., Conjeevaram, H., Di Bisceglie, A. M., Park, Y., Savarese, B., Kleiner, D., Tsokos, M., Luciano, C., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510263331702 · Cited by 616
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Weltman, M. D., Farrell, G. C., Hall, P., Ingelman-Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 614
Benichou, C., Danan, G., & Flahault, A. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90102-7 · Cited by 491
Association of Acetaminophen Hepatotoxicity With Fasting and Ethanol Use
Whitcomb, D. C. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520230055038 · Cited by 470
Huang, Y.-S., Chern, H.-D., Su, W.-J., Wu, J.-C., Lai, S.-L., Yang, S.-Y., Chang, F.-Y., & Lee, S.-D. (2002) · Hepatology · doi:10.1053/jhep.2002.32102 · Cited by 432
Effect of age and gender on the activity of human hepatic CYP3A
Hunt, C. M., Westerkam, W. R., & Stave, G. M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90010-g · Cited by 426
Acetaminophen Hepatotoxicity in Alcoholics: A Therapeutic Misadventure
SEEFF, L. B., CUCCHERINI, B. A., ZIMMERMAN, H. J., ADLER, E., & BENJAMIN, S. B. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-3-399 · Cited by 424
Acetaminophen Toxicity in an Urban County Hospital
Schiødt, F. V., Rochling, F. A., Casey, D. L., & Lee, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371602 · Cited by 422
Self-citationMitochondria in Steatohepatitis
Pessayre, D., Berson, A., Fromenty, B., & Mansouri, A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12929 · Cited by 391
Nolan, C. M., Goldberg, S. V., & Buskin, S. E. (1999) · JAMA · doi:10.1001/jama.281.11.1014 · Cited by 368
Human cytochromes P450: problems and prospects
Gonzalez, F. J. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90107-h · Cited by 363
Apoptosis-regulating proteins as targets for drug discovery
Reed, J. C. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02026-3 · Cited by 328
Beaune, P., Dansette, P. M., Mansuy, D., Kiffel, L., Finck, M., Amar, C., Leroux, J. P., & Homberg, J. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.551 · Cited by 320
Medina, I., Mills, J., Leoung, G., Hopewell, P. C., Lee, B., Modin, G., Benowitz, N., & Wofsy, C. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231202 · Cited by 320
Therapeutic misadventures with acetaminophen: Hepatoxicity after multiple doses in children
Heubi, J. E., Barbacci, M. B., & Zimmerman, H. J. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70479-2 · Cited by 318
Modulation of Acetaminophen-Induced Hepatotoxicity by the Xenobiotic Receptor CAR
Zhang, J., Huang, W., Chua, S. S., Wei, P., & Moore, D. D. (2002) · Science · doi:10.1126/science.1073502 · Cited by 316
Hepatotoxicity of herbal remedies.
MacGregor, F. B., Abernethy, V. E., Dahabra, S., Cobden, I., & Hayes, P. C. (1989) · BMJ · doi:10.1136/bmj.299.6708.1156 · Cited by 311
Banks, A. T., Zimmerman, H. J., Ishak, K. G., & Harter, J. G. (1995) · Hepatology · doi:10.1002/hep.1840220320 · Cited by 301
HLA association of amoxicillin-clavulanate–induced hepatitis
Hautekeete, M. L., Horsmans, Y., van Waeyenberge, C., Demanet, C., Henrion, J., Verbist, L., Brenard, R., Sempoux, C., Michielsen, P. P., Yap, P. S. H., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70404-x · Cited by 285
Larrey, D., Vial, T., Pauwels, A., Castot, A., Biour, M., David, M., & Michel, H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-129 · Cited by 271
Drug–Induced Liver Injury: Mechanisms and Test Systems
Bissell, M. D., Gores, G. J., Laskin, D. L., & Hoofnagle, J. H. (2001) · Hepatology · doi:10.1053/jhep.2001.23505 · Cited by 267
Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients
Lewis, J. H., Ranard, R. C., Caruso, A., Jackson, L. K., Mullick, F., Ishak, K. G., Seeff, L. B., & Zimmerman, H. J. (1989) · Hepatology · doi:10.1002/hep.1840090504 · Cited by 266
Geubel, A., De Galocsy, C., Alves, N., Rahier, J., & Dive, C. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90672-8 · Cited by 234
Isoniazid-Associated Hepatitis: Report of an Outbreak 1
Garibaldi, R. A., Drusin, R. E., Ferebee, S. H., & Gregg, M. B. (1972) · American Review of Respiratory Disease · doi:10.1164/arrd.1972.106.3.357 · Cited by 232
Two Cases of Severe Clinical and Histologic Hepatotoxicity Associated with Troglitazone
Gitlin, N., Julie, N. L., Spurr, C. L., Lim, K. N., & Juarbe, H. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-1-199807010-00008 · Cited by 230
Yun, C. H., Okerholm, R. A., & Guengerich, F. P. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07393-3 · Cited by 229
Takahashi, T., Lasker, J. M., Rosman, A. S., & Lieber, C. S. (1993) · Hepatology · doi:10.1002/hep.1840170213 · Cited by 228
George, J., Murray, M., Byth, K., & Farrell, G. C. (1995) · Hepatology · doi:10.1002/hep.1840210121 · Cited by 227
DRUG METABOLISM BY CYTOCHROMES P450 IN THE LIVER AND SMALL BOWEL
Watkins, P. B. (1992) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00046-7 · Cited by 220
Chitturi, S., & Farrell, G. C. (2000) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-000-0034-7 · Cited by 220
Chitturi, S., & George, J. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30102 · Cited by 216
Comparison of Two Clinical Scales for Causality Assessment in Hepatotoxicity
Lucena, M. I., Camargo, R., Andrade, R. J., Perez-Sanchez, C. J., & De La Cuesta, F. S. (2001) · Hepatology · doi:10.1053/jhep.2001.20645 · Cited by 212
Hepatic Failure in a Patient Taking Rosiglitazone
Forman, L. M., Simmons, D. A., & Diamond, R. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00005 · Cited by 212
Chiu, J., Nussbaum, J., Bozzette, S., Tilles, J. G., Young, L. S., Leedom, J., Heseltine, P. N. R., McCutchan, J. A., & California Collaborative Treatment Group (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-5-358 · Cited by 204
Fatal and Nonfatal Hepatotoxicity Associated with Flutamide
Wysowski, D. K., Freiman, J. P., Tourtelot, J. B., & Horton, M. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-11-199306010-00006 · Cited by 197
Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case Report
Al-Salman, J., Arjomand, H., Kemp, D. G., & Mittal, M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00006 · Cited by 196
Acute Hepatitis Associated with the Chinese Herbal Product Jin Bu Huan
Woolf, G. M., Petrovic, L. M., Rojter, S. E., Wainwright, S., Villamil, F. G., Katkov, W. N., Michieletti, P., Wanless, I. R., Stermitz, F. R., Beck, J. J., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-10-199411150-00001 · Cited by 196
Troglitazone-Induced Hepatic Failure Leading to Liver Transplantation: A Case Report
Neuschwander-Tetri, B. A., Isley, W. L., Oki, J. C., Ramrakhiani, S., Quiason, S. G., Phillips, N. J., & Brunt, E. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-1-199807010-00009 · Cited by 195
Chronic Active and Lupoid Hepatitis Caused by a Laxative, Oxyphenisatin
Reynolds, T. B., Peters, R. L., & Yamada, S. (1971) · New England Journal of Medicine · doi:10.1056/nejm197110072851501 · Cited by 195
Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.
Larrey, D., Vial, T., Micaleff, A., Babany, G., Morichau-Beauchant, M., Michel, H., & Benhamou, J. P. (1992) · Gut · doi:10.1136/gut.33.3.368 · Cited by 190
Stedman, C. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30104 · Cited by 188
Severe Hepatotoxicity Associated with the Dietary Supplement LipoKinetix
Favreau, J. T., Ryu, M. L., Braunstein, G., Orshansky, G., Park, S. S., Coody, G. L., Love, L. A., & Fong, T.-L. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-8-200204160-00008 · Cited by 187
P450 Enzymes: Inhibition Mechanisms, Genetic Regulation and Effects of Liver Disease
Murray, M. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199223020-00005 · Cited by 182
Acute hepatitis induced by greater celandine (Chelidonium majus)
Benninger, J., Schneider, H. T., Schuppan, D., Kirchner, T., & Hahn, E. G. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70410-5 · Cited by 173
Hepatic side-effects of antibiotics
Westphal, J. F., Vetter, D., & Brogard, J. M. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.3.387 · Cited by 173
Tolcapone and Hepatotoxic Effects
Olanow, C. W. (2000) · Archives of Neurology · doi:10.1001/archneur.57.2.263 · Cited by 173
Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity
Schmidt, L. E., Dalhoff, K., & Poulsen, H. E. (2002) · Hepatology · doi:10.1053/jhep.2002.32148 · Cited by 172
Mixed Hepatocellular–Cholestatic Liver Injury after Pioglitazone Therapy
May, L. D., Lefkowitch, J. H., Kram, M. T., & Rubin, D. E. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-6-200203190-00008 · Cited by 167
Human cytochrome P-450 enzymes
Guengerich, F. P. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90136-d · Cited by 162
Hepatic Necrosis Associated with Halothane Anesthesia
Lindenbaum, J., & Leifer, E. (1963) · New England Journal of Medicine · doi:10.1056/nejm196303072681004 · Cited by 159
Fulminant Hepatic Failure Associated with 2′,3′-Dideoxyinosine (ddI)
Lai, K. K., Gang, D. L., Zawacki, J. K., & Cooley, T. P. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-4-283 · Cited by 157
The QT Interval and Torsade de Pointes
Moss, A. J. (1999) · Drug Safety · doi:10.2165/00002018-199921001-00002 · Cited by 154
Hepatitis C Virus Infection and Bone Marrow Transplantation: A Cohort Study With 10–Year Follow–Up
Strasser, S. I., Myerson, D., Spurgeon, C. L., Sullivan, K. M., Storer, B. E., Schoch, G. H., Kim, S., Flowers, M. E. D., & McDonald, G. B. (1999) · Hepatology · doi:10.1002/hep.510290609 · Cited by 152
Hepatomegaly with severe steatosis in HIV-seropositive patients
Freiman, J. P., Helfert, K. E., Hamrell, M. R., & Stein, D. S. (1993) · AIDS · doi:10.1097/00002030-199303000-00012 · Cited by 151
Amanita poisoning: Treatment and the role of liver transplantation
Klein, A. S., Hart, J., Brems, J. J., Goldstein, L., Lewin, K. J., & Busuttil, R. W. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90267-2 · Cited by 150
Herbal hepatotoxicity: An expanding but poorly defined problem
Chitturi, S., & Farrell, G. C. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02349.x · Cited by 144
French, S. W., Wong, K., Jui, L., Albano, E., Hagbjörk, A.-L., & Ingelman‐Sundberg, M. (1993) · Experimental and Molecular Pathology · doi:10.1006/exmp.1993.1006 · Cited by 143
Chronic Excessive Acetaminophen Use and Liver Damage
BARKER, J. D., de CARLE, D. J., & ANURAS, S. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-3-299 · Cited by 142
Lactic Acidosis Complicating the Acquired Immunodeficiency Syndrome
Chattha, G., Arieff, A. I., Cummings, C., & Tierney, Jr. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-1-199301010-00007 · Cited by 137
Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults
Thummel, K. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.106574 · Cited by 131
Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis
Robin, M., Roy, M. L., Descatoire, V., & Pessayre, D. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)82329-x · Cited by 129
Mechanisms of halothane toxicity: Novel insights
Gut, J., Christen, U., & Huwyler, J. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90047-h · Cited by 126
Ticrynafen-Associated Hepatic Injury: Analysis of 340 Cases
Zimmerman, H. J., Lewis, J. H., Ishak, K. G., & Maddrey, W. C. (1984) · Hepatology · doi:10.1002/hep.1840040223 · Cited by 125
Causality Assessment Versus Guilt–By–Association in Drug Hepatotoxicity
Kaplowitz, N. (2001) · Hepatology · doi:10.1053/jhep.2001.21083 · Cited by 122
[Toxic and drug-induced hepatitis].
de Albornoz, M. M. C., Echebarría, R. U., Alvarez, J. S., Herranz, M. A. S., Bragado, F. G., & Puente, A. R. (1988) · PubMed · Cited by 122
Centrilobular Hepatic Necrosis and Acute Renal Failure in "Solvent Sniffers"
Baerg, R. D., & KIMBERG, D. V. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-73-5-713 · Cited by 121
Hepatotoxicity of germander in mice
Loeper, J., Descatoire, V., Lettéron, P., Moulis, C., Degott, C., Dansette, P. M., Fau, D., & Pessayre, D. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90606-8 · Cited by 119
CASE REPORT: Troglitazone-Induced Fulminant Hepatic Failure
Murphy, E. J., Davern, T. J., Shakil, A. O., Shick, L., Masharani, U., Chow, H., Freise, C., Lee, W. M., & Bass, N. M. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005405526283 · Cited by 111
Self-citationHepatic dysfunction accompanying acute cocaine intoxication
Silva, M., Roth, D., Reddy, K. R. R. M., Fernandez, J., Albores‐Saavedra, J., & Schiff, E. R. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90832-v · Cited by 102
Nefazodone-Induced Liver Failure: Report of Three Cases
Aranda-Michel, J., Koehler, A., Bejarano, P. A., Poulos, J. E., Luxon, B. A., Mobin Khan, C., Ee, L. C., Balistreri, W. F., & Weber, F. L. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-4-199902160-00013 · Cited by 102
Anti-tuberculous therapy and acute liver failure
Mitchell, I., Wendon, J. A., Fitt, S., & Williams, R. L. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90468-9 · Cited by 97
Hepatotoxicity associated with sustained-release niacin
Dalton, T. A., & Berry, R. S. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90689-9 · Cited by 97
Adedoyin, A., Arns, P. A., Richards, W. O., Wilkinson, G. R., & Branch, R. A. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90017-0 · Cited by 96
Davies, M. H., Harrison, R. F., Elias, E., & Hübscher, S. G. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80476-3 · Cited by 95
Bonkovsky, H. L., Kane, R. E., Jones, D. P., Galinsky, R. E., & Banner, B. (1994) · Hepatology · doi:10.1002/hep.1840190511 · Cited by 95
Trovafloxacin-Induced Acute Hepatitis
Lucena, M. I., Andrade, R. J., Rodrigo, L., Salmeron, J., Alvarez, A., Lopez-Garrido, M. J., Camargo, R., & Alcantara, R. (2000) · Clinical Infectious Diseases · doi:10.1086/313680 · Cited by 95
Hepatic cytochrome P-4503A (CYP3A) activity in the elderly
Hunt, C. M., Westerkam, W. R., Stave, G. M., & Wilson, J. A. P. (1992) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(92)90106-n · Cited by 93
Antecedent liver disease and drug toxicity
Schenker, S., Martin, R. R., & Hoyumpa, A. M. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80325-0 · Cited by 90
Acute liver failure associated with antiretroviral treatment for HIV: a report of six cases
Clark, S. J., Creighton, S., Portmann, B., Taylor, C., Wendon, J. A., & Cramp, M. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00291-4 · Cited by 90
Herbal Hepatitis: Subacute Hepatic Necrosis Secondary to Chaparral Leaf
Katz, M., & Saibil, F. (1990) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199004000-00021 · Cited by 89
Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation
Fontana, R. J., McCashland, T. M., Benner, K. G., Appelman, H. D., Gunartanam, N. T., Wisecarver, J. L., Rabkin, J. M., Lee, W. M., & Acute Liver Failure Study Group (1999) · Liver Transplantation and Surgery · doi:10.1002/lt.500050607 · Cited by 87
Self-citationKetoconazole-induced fulminant hepatitis necessitating liver transplantation
Knight, T. E., Shikuma, C. Y., & Knight, J. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70214-m · Cited by 85
Rigas, B., ROSENFELD, L. E., BARWICK, K. W., ENRIQUEZ, R., HELZBERG, J., BATSFORD, W. P., Josephson, M. E., & RIELY, C. A. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-3-348 · Cited by 84
HepG2 Cells: An in Vitro Model for P450-Dependent Metabolism of Acetaminophen
Roe, A. L., SNAWDER, J. E., Benson, R. W., Roberts, D. W., & Casciano, D. A. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1003 · Cited by 82
Drug-Induced Allergic Hepatitis
Pohl, L. (1990) · Seminars in Liver Disease · doi:10.1055/s-2008-1040486 · Cited by 77
Mesalazine (5-aminosalicylic acid) induced chronic hepatitis
Deltenre, P., Berson, A., Marcellin, P., Degott, C., Biour, M., & Pessayre, D. (1999) · Gut · doi:10.1136/gut.44.6.886 · Cited by 77
Hepatic toxicity of Vitamin A and synthetic retinoids
FALLON, M. B., & BOYER, J. L. (1990) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1990.tb01635.x · Cited by 77
Acute Liver Disease Associated with Erythromycins, Sulfonamides, and Tetracyclines
Carson, J. L., Strom, B. L., Duff, A., Gupta, A., Shaw, M., Lundin, F. E., & Das, K. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_1-199310010-00005 · Cited by 77
Association of acetaminophen hepatotoxicity with fasting and ethanol use
Whitcomb, D. C. (1994) · JAMA · doi:10.1001/jama.272.23.1845 · Cited by 76
König, S. A., Schenk, M., Sick, C., Holm, E., Heubner, C., Weiss, A., König, I. R., & Hehlmann, R. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00814.x · Cited by 76
Metformin-induced Acute Hepatitis
Babich, M., Pike, I. M., & Shiffman, M. L. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00088-6 · Cited by 71
Potentiation of Cocaine‐Mediated Hepatotoxicity by Acute and Chronic Ethanol
Boyer, C. S., & Petersen, D. R. (1990) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1990.tb00441.x · Cited by 66
Celecoxib-Induced Acute Pancreatitis and Hepatitis: A Case Report
Carrillo-Jimenez, R., & Nurnberger, M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.553 · Cited by 66
Bernal, W. E., Donaldson, P. T., Underhill, J. A., Wendon, J. A., & Williams, R. L. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80178-5 · Cited by 64
Acute cholestatic hepatitis associated with pravastatin
Hartleb, M. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00147-1 · Cited by 63
Immunoallergic drug-induced hepatitis: lessons from halothane
Kenna, J. G. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)82327-6 · Cited by 63
Hepatitis associated with terbinafine therapy: three case reports and a review of the literature
Gupta, A. K., Rosso, D., Lynde, Brown, & Shear (1998) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.1998.00321.x · Cited by 61
Trazodone-induced hepatotoxicity: a case report with comments on drug-induced hepatotoxicity
Fernandes, N. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00839-4 · Cited by 59
Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim.
Alberti‐Flor, J. J., Hernandez, M. E., Jp, F., Howell, S., & Jeffers, L. J. (1989) · PubMed · Cited by 56
Severe Hypersensitivity to Diphenylhydantoin with Circulating Antibodies to the Drug
KLECKNER, H. B., YAKULIS, V., & HELLER, P. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-4-522 · Cited by 56
Fulminant hepatitis after lisinopril administration
Larrey, D. G., Babany, G., Bernuau, J., Andrieux, J., Degott, C., Pessayre, D., & Benhamou, J. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90496-n · Cited by 55
KAVA-INDUCED FULMINANT HEPATIC FAILURE
Campo, J. V., McNabb, J., Perel, J. M., Mazariegos, G. V., Hasegawa, S. L., & Reyes, J. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200206000-00001 · Cited by 54
Drug points: Paroxetine and hepatotoxicity
Benbow, S. J., & Gill, G. (1997) · BMJ · doi:10.1136/bmj.314.7091.1387a · Cited by 53
Modulation of the levels of cytochromes P450 in rat liver and lung by dietary lipid
Yoo, J.-S. H., Smith, T. J., Ning, S. M., Mao-Jung, L., Thomas, P. E., & Yang, C. S. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90141-5 · Cited by 53
Toxic hepatitis by clozapine treatment
Kellner, M. B., Wiedemann, K., Krieg, J. C., & Berg, P. A. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.985b · Cited by 51
Hepatotoxicity from paracetamol self‐poisoning in western Sydney: a continuing challenge
Brotodihardjo, A. E., Batey, R. G., Farrell, G. C., & Byth, K. (1992) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1992.tb137246.x · Cited by 50
Barnett, C. R., Abbott, R. A., Bailey, C. J., Flatt, P. R., & Ioannides, C. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90724-w · Cited by 49
Norfloxacin-induced hepatotoxicity
López-Navidad, A., Domingo, P., Cadafalch, J. P. I., & Farrerons, J. (1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90125-b · Cited by 46
Acetaminophen Poisoning and Liver Function
(1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311913 · Cited by 45
Augmentin‐induced jaundice with a fatal outcome
Hebbard, G., Smith, K. G. C., Gibson, P. R., & Bhathal, P. S. (1992) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1992.tb139752.x · Cited by 45
Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments
Tran, A., Housset, C., Boboc, B., Tourani, J. M., Carnot, F., & Berthelot, P. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90905-q · Cited by 45
Acute fatal hepatitis related to levofloxacin
Spahr, L., Rubbia-Brandt, L., Marinescu, O., Armenian, B., & Hadengue, A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00082-4 · Cited by 44
Chlorzoxazone Hepatotoxic Reactions
Powers, B. J. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.146.6.1183 · Cited by 44
Froomes, P. R. A., Morgan, D. J., Smallwood, R. A., & Angus, P. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70075-2 · Cited by 42
Four Cases of Severe Hepatotoxicity Associated With Pemoline: Possible Autoimmune Pathogenesis
Rosh, J. R., Dellert, S. F., Narkewicz, M., Birnbaum, A., & Whitington, G. (1998) · Pediatrics · doi:10.1542/peds.101.5.921 · Cited by 40
Fatal Hepatitis Associated With Ranitidine
Ribeiro, J. M. M. C., Lucas, M. B., Baptista, A., & Victorino, R. M. M. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.t01-1-01808.x · Cited by 38
Venlafaxine-Associated Hepatitis
Cardona, X., Avila, A., & Castellanos, P. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-5-200003070-00016 · Cited by 37
Nankivell, B. J., Bhandari, P., & Koller, L. J. (1994) · BMJ · doi:10.1136/bmj.309.6951.378 · Cited by 35
Ofloxacin-Induced Acute Severe Hepatitis
Blum, A. (1991) · Southern Medical Journal · doi:10.1097/00007611-199109000-00027 · Cited by 34
Fluoxetine-induced hepatitis: why is postmarketing surveillance needed?
Capellà, D., Bruguera, M., Figueras, A., & Laporte, J. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050671 · Cited by 32
Effects of interleukin 1α on the activities and gene expressions of the cytochrome p450iid subfamily
Kazutaka, K., Hirohito, Y., Matsuo, Y., Mikio, N., & Ichikawa, Y. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90485-2 · Cited by 32
Drug metabolism and hepatotoxicity.
Tredger, J. M., & Davis, M. R. (1991) · Gut · doi:10.1136/gut.32.suppl.s34 · Cited by 29
Iqbal, M., Goenka, P., Young, M. F., Thomas, E., & Borthwick, T. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026658320577 · Cited by 29
Risperidone-induced Hepatotoxicity
Benazzi, F. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979337 · Cited by 28
Gabapentin-associated hepatotoxicity
Lasso-de-la-Vega, M., Zapater, P., Such, J. M., Pérez‐Mateo, M., & Horga, J. F. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.05357.x · Cited by 28
Baylor, P. A., & Williams, K. (1999) · Clinical Infectious Diseases · doi:10.1086/313475 · Cited by 27
Pol, S., Vallet‐Pichard, A., & Fontaine, H. (2002) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2002.00326.x · Cited by 27
CASE REPORT: Hepatic Injury Due to Troglitazone
Malik, A. H., Prasad, P. V. L. N. S., Saboorian, M. H., Thiele, D. L., & Malet, P. F. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005450519498 · Cited by 27
Burckart, G. J., Frye, R. F., Kelly, P., Branch, R. A., Jain, A., Fung, J. J., Starzl, T. E., & Venkataramanan, R. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90161-8 · Cited by 26
Combined nitrofurantoin toxicity to liver and lung.
Reinhart, H. H., Reinhart, E., Korlipara, P., et al. (1992) · PubMed · Cited by 26
Combined nitrofurantoin toxicity to liver and lung
Reinhart, H., Reinhart, E., Korlipara, P., & Peleman, R. R. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)70040-i · Cited by 26
Gradon, J. D., Chapnick, E. K., & Sepkowitz, D. V. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00542.x · Cited by 25
Cai, H., & Guengerich, F. P. (2000) · Chemical Research in Toxicology · doi:10.1021/tx000185n · Cited by 24
Indinavir-associated hepatitis in patients with advanced HIV infection
Vergis, E. N., Paterson, D. L., & Singh, N. (1998) · International Journal of STD & AIDS · doi:10.1258/0956462981920883 · Cited by 24
Autoantibodies against Cytochromes P‐450 in Drug‐Induced Autoimmune Hepatitis
Beaune, P. H., & Bourdi, M. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35929.x · Cited by 24
Hepatic Dysfunction After Repeated Isoflurane Administration
Scheider, D. M., Klygis, L. M., Tsang, T.-K., & Caughron, M. C. (1993) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199309000-00017 · Cited by 23
Fatal submassive necrosis of the liver associated with piroxicam.
Planas, R., de León, R., Quer, J. C., Barranco, C., Bruguera, M., & Ma, G. (1990) · PubMed · Cited by 23
Early Hepatitis during Intravenous Amiodarone Administration
Morelli, S., Guido, V., Marzio, P. D., Aguglia, F., & BALSANO, F. (2008) · Cardiology · doi:10.1159/000174796 · Cited by 22
Severe cholestasis associated with ticlopidine.
Grimm, I. S., & Litynski, J. J. (1994) · PubMed · Cited by 21
NIH, PDA seek lessons from hepatitis B drug trial deaths
Macilwain, C. (1993) · Nature · doi:10.1038/364275d0 · Cited by 20
FDA fails to reduce accessibility of paracetamol despite 450 deaths a year
Moynihan, R. (2002) · BMJ · doi:10.1136/bmj.325.7366.678 · Cited by 19
Flutamide-induced acute hepatitis in advanced prostate cancer patients
Kraus, I., Vitezić, D., & Oguić, R. (2001) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp39395 · Cited by 18
Norfloxacin-Induced Acute Cholestatic Hepatitis in A Patient With Alcoholic Liver Cirrhosis
Romero‐Gómez, M., García, E. S., & Fernández, C. M. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.02324.x · Cited by 17
Expression of cytokines and factors modulating apoptosis by human sinusoidal leucocytes
Jonsson, J. R., Edwards-Smith, C. J., Catania, S. C., Morotomi, Y., Hogan, P., Clouston, A. D., Bansal, A. S., Lynch, S. V., Strong, R. W., & Powell, E. E. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80388-8 · Cited by 17
Hepatotoxicity Associated with Cocaine Abuse
Thiel, D. H. V., & Perper, J. A. (1992) · Recent developments in alcoholism · doi:10.1007/978-1-4899-1648-8_16 · Cited by 15
Multiorgan failure induced by atorvastatin
Sreenarasimhaiah, J., Shiels, P., & Lisker‐Melman, M. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01178-6 · Cited by 15
Subfulminant hepatitis requiring liver transplantation after benzarone administration
Géhénot, M., Horsmans, Y., Rahier, J., & Geubel, A. P. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80159-x · Cited by 15
Endogenous and exogenous factors modifying the activity of human liver cytochrome P-450 enzymes
Wolff, T., & Strecker, M. (1992) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(11)80241-1 · Cited by 14
Expression of hepatic microsomal cytochrome P450s as altered by uremia
Ikemoto, S., Imaoka, S., Hayahara, N., Maekawa, M., & Funae, Y. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90320-i · Cited by 13
Pharmacokinetics of Fluconazole in Trauma Patients with Postpyloric Feeding Tubes
Davis, G. A., Rapp, R. P., Kearney, P. A., & Ensom, M. H. H. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a055 · Cited by 13
Cholestatic hepatitis associated with the use of nafcillin.
Mazuryk, H., Kastenberg, D. M., Rubin, R., & Sj, M. (1993) · PubMed · Cited by 13
Carbamazepine, hepatotoxicity, organic solvents, and paints
Kaufman, K. R. (1999) · Seizure · doi:10.1053/seiz.1999.0281 · Cited by 11
Diclofenac‐induced hepatitis: case report and literature review
Ramakrishna, B., & Viswanath, N. (1994) · Liver International · doi:10.1111/j.1600-0676.1994.tb00052.x · Cited by 10
Doxepin‐induced recurrent acute hepatitis
Keegan, A. D. (1993) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1993.tb01843.x · Cited by 10
Losartan-induced hepatotoxicity
Bosch, X. (1997) · JAMA · doi:10.1001/jama.278.19.1572 · Cited by 10
Cholestatic hepatitis occurring shortly after etretinate therapy
Kano, Y., Fukuda, M., Shiohara, T., & Nagashima, M. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(09)80252-1 · Cited by 9
“Ecstasy” -Induced Hepatitis in an Active Duty Soldier
Hwang, I., Daniels, A. M., & Holtzmuller, K. C. (2002) · Military Medicine · doi:10.1093/milmed/167.2.155 · Cited by 9
Oxacillin Hepatotoxicity in HIV-infected Patients
SALIBA, B. C., & Herbert, P. N. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-12-199406150-00018 · Cited by 8
Terbutaline hepatitis in pregnancy: report of two cases and literature review.
Pg, Q., Bw, S., Tavill, A. S., & Al, G. (1994) · PubMed · Cited by 6
Picon, M., Causse, X., Gelas, P., Retornaz, G., TREPO, C. G., & Boulétreau, P. (1991) · PubMed · Cited by 5
Oral contraceptives and hepatocellular carcinoma
Brosens, I. A., JOHANNISSON, E., Baulieu, E. E., Benagiano, G., Cooke, I. D., Goldzieher, J. W., Hammerstein, J., Haspels, A. A., Lunenfeld, B., Potts, M., et al. (1986) · BMJ · doi:10.1136/bmj.292.6536.1667-a · Cited by 4
Aithal, G. P., Daly, A. K., Leathart, J. B. S., Yuanneng, C. P., & Day, C. P. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)86050-3 · Cited by 3
Research works printed but not linked: 9
- Yun CH, 1993, Drug Metab Dispos, 21, 403
- Chitturi S, 2001, Semin Gastrointest Dis, 12, 113
- Wang K, 1999, Zhonghua Yi Xue Za Zhi (Taipei), 62, 369
- George J, 1995, Hepatology, 21, 120
- Meadows M, 2001, FDA Consum, 35, 8
- Piliero PJ, 2001, AIDS Read, 11, 379
- 10.1111/j.1572-0241.1999.01091.x · doi:10.1111/j.1572-0241.1999.01091.x · Paper page
- Fernandes NF, 2000, Am J Gastroenterol, 95, 532, 10.1111/j.1572-0241.2000.t01-1-01780.x · doi:10.1111/j.1572-0241.2000.t01-1-01780.x · Paper page
- Graham DJ, 2002, Hepatology, 36, 168A
Cited by
Liver enzyme alteration: a guide for clinicians
Giannini, E. G. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040752 · Cited by 2,016
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114147 · Cited by 1,920
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Navarro, V. J., & Senior, J. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052270 · Cited by 811
Metadata
- Authors
- Lee, W. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Lee, William M.
- ORCID
- Lee, William M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-07-31
- Volume
- 349
- Issue
- 5
- Pages
- 474-485
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3021092633
- Cited by
- 1,594
- References
- 180
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 33 · 2023: 41 · 2022: 44 · 2021: 44 · 2020: 53 · 2019: 69 · 2018: 69 · 2017: 75 · 2016: 84 · 2015: 74 · 2014: 95 · 2013: 88 · 2012: 88
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- drug-induced liver injury, acute liver failure, idiosyncratic drug reactions, adverse drug reactions, drug approval, hepatotoxicity monitoring, liver transplantation
- MeSH terms
- Troglitazone, Anti-Inflammatory Agents, Non-Steroidal, Benzophenones, Bromobenzenes, Chromans, Pharmaceutical Preparations, Humans, Hypoglycemic Agents, Liver, Liver Cirrhosis, Liver Diseases, Liver Function Tests, Pharmacology, Thiazoles, Drug Approval, Thiazolidinediones, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.